http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2010006388-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27a71ddaaa2f5a8c228fc6cb3f3b3098
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-04
filingDate 2008-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16dd94cb036029e023a11f2efb4cbe72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50a6d33cf76c3faafa370b89365a8cf0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34a58182fc82e2a2acfd81cd59f838b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5f4e6f01666c3457fed2aada545a0e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bccf4bcb49865a9b30f81002733060af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b5e3550eb7a15bd645b0b578247bb7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c26a921e49e4b16be4e92a81b6331dda
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3318a3ebb2dde25e55045d2995947d66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab6e244a5e5e5a7354a413b340e7e007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1c3c20d72f7609dc3089055f05ffd27
publicationDate 2010-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2010006388-A
titleOfInvention BIS-PIRIDILPIRIDONAS AS ANTAGONISTS OF THE RECEIVER 1 OF THE CONCENTRATING HORMONE OF MELANINA.
abstract The invention provides novel bis-pyridylpyridones that are antagonists in the melanin concentrating hormone receptor 1 (MCHR1), pharmaceutical compositions containing them, methods for their preparation, and their use in therapy and for the treatment of obesity and / or diabetes.
priorityDate 2007-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID83567
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66799510
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID574232
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID207911
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID540119
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2847
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410493799

Total number of triples: 37.